Atorvastatin and prostate cancer - a phase 2 clinical trial

被引：0
|
作者：
Murtola, Teemu J.
Riikonen, Jarno
Syvala, Heimo
Tolonen, Teemu
Koskimaki, Juha
Pakarainen, Tomi
Kaipia, Antti
Isotalo, Taina
Kujala, Paula
Tammela, Teuvo
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT133
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT133
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer
    Gross, Mitchell E.
    Agus, David B.
    Dorff, Tanya B.
    Pinski, Jacek K.
    Quinn, David, I
    Castellanos, Olga
    Gilmore, Patrick
    Shih, Jean C.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (01) : 61 - 68
  • [42] Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer
    Graff, P.
    Malavaud, B.
    Portalez, D.
    Brun, T.
    Aziza, R.
    Lusque, A.
    Filleron, T.
    Bachaud, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E235 - E236
  • [43] A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer
    Landon C. Brown
    Susan Halabi
    Jason A. Somarelli
    Michael Humeniuk
    Yuan Wu
    Taofik Oyekunle
    Lauren Howard
    Jiaoti Huang
    Monika Anand
    Catrin Davies
    Prekshaben Patel
    Janet Staats
    Kent J. Weinhold
    Michael R. Harrison
    Tian Zhang
    Daniel J. George
    Andrew J. Armstrong
    Prostate Cancer and Prostatic Diseases, 2022, 25 : 762 - 769
  • [44] A phase 2 trial of avelumab in men with aggressive-variant or neuroendocrine prostate cancer
    Brown, Landon C.
    Halabi, Susan
    Somarelli, Jason A.
    Humeniuk, Michael
    Wu, Yuan
    Oyekunle, Taofik
    Howard, Lauren
    Huang, Jiaoti
    Anand, Monika
    Davies, Catrin
    Patel, Prekshaben
    Staats, Janet
    Weinhold, Kent J.
    Harrison, Michael R.
    Zhang, Tian
    George, Daniel J.
    Armstrong, Andrew J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2022, 25 (04) : 762 - 769
  • [45] Phase 2 trial of monoamine oxidase inhibitor phenelzine in biochemical recurrent prostate cancer
    Mitchell E. Gross
    David B. Agus
    Tanya B. Dorff
    Jacek K. Pinski
    David I. Quinn
    Olga Castellanos
    Patrick Gilmore
    Jean C. Shih
    Prostate Cancer and Prostatic Diseases, 2021, 24 : 61 - 68
  • [46] Randomized phase 2 trial of ketoconazole and ketoconazole/doxorubicin in androgen independent prostate cancer
    Millikan, R
    Baez, L
    Banerjee, T
    Wade, J
    Edwards, K
    Winn, R
    Smith, TL
    Logothetis, C
    UROLOGIC ONCOLOGY, 2001, 6 (03): : 111 - 115
  • [47] Prostate cancer chemoprevention: Update of the prostate cancer prevention trial findings and implications for clinical practice
    Jamey A. Sarvis
    Ian M. Thompson
    Current Oncology Reports, 2008, 10 : 529 - 532
  • [48] Prostate Cancer Chemoprevention: Update of the Prostate Cancer Prevention Trial Findings and Implications for Clinical Practice
    Sarvis, Jamey A.
    Thompson, Ian M.
    CURRENT ONCOLOGY REPORTS, 2008, 10 (06) : 529 - 532
  • [49] STEREOTACTIC BODY RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER: INTERIM RESULTS OF A PROSPECTIVE PHASE II CLINICAL TRIAL
    King, Christopher R.
    Brooks, James D.
    Gill, Harcharan
    Pawlicki, Todd
    Cotrutz, Cristian
    Presti, Joseph C., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 73 (04): : 1043 - 1048
  • [50] Atorvastatin Versus Placebo for Prostate Cancer Before Radical Prostatectomy-A Randomized, Double-blind, Placebo-controlled Clinical Trial
    Murtola, Teemu J.
    Syvala, Heimo
    Tolonen, Teemu
    Helminen, Mika
    Riikonen, Jarno
    Koskimaki, Juha
    Pakarainen, Tomi
    Kaipia, Antti
    Isotalo, Taina
    Kujala, Paula
    Tammela, Teuvo L. J.
    EUROPEAN UROLOGY, 2018, 74 (06) : 697 - 701
12345